2-pyrazinoylguanidine has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, KH; Chambers, CE; Demers, LM; Passananti, GT; Seaton, TD; Vesell, ES | 1 |
| Beyer, KH; Vesell, ES | 1 |
| Beyer, KH; Chambers, CE; Helm, C; Passananti, GT; Vesell, ES | 1 |
1 review(s) available for 2-pyrazinoylguanidine and Hypertension
| Article | Year |
|---|---|
Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Biological Transport, Active; Diabetes Mellitus, Type 2; Guanidines; Humans; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Kidney Diseases; Pyrazines; Rats | 2000 |
1 trial(s) available for 2-pyrazinoylguanidine and Hypertension
| Article | Year |
|---|---|
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects.
Topics: Aged; Blood Pressure; Cholesterol; Dose-Response Relationship, Drug; Female; Guanidines; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Renin-Angiotensin System; Single-Blind Method | 1992 |
1 other study(ies) available for 2-pyrazinoylguanidine and Hypertension
| Article | Year |
|---|---|
Pyrazinoylguanidine downregulates the glucose fatty-acid cycle in hypertensive, hyperinsulinemic diabetic patients.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Fatty Acids; Female; Glucose Tolerance Test; Guanidines; Humans; Hypertension; Male; Middle Aged; Pyrazines | 1994 |